Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Applications of a 7-day Caco-2 cell model in drug discovery and development.

Peng Y, Yadava P, Heikkinen AT, Parrott N, Railkar A.

Eur J Pharm Sci. 2014 Jun 2;56:120-30. doi: 10.1016/j.ejps.2014.02.008. Epub 2014 Feb 24.

PMID:
24576578
[PubMed - in process]
2.

Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.

Gupta D, Varghese Gupta S, Dahan A, Tsume Y, Hilfinger J, Lee KD, Amidon GL.

Mol Pharm. 2013 Feb 4;10(2):512-22. doi: 10.1021/mp300564v. Epub 2013 Jan 4.

PMID:
23244438
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Caco-2 cell permeability assays to measure drug absorption.

van Breemen RB, Li Y.

Expert Opin Drug Metab Toxicol. 2005 Aug;1(2):175-85. Review.

PMID:
16922635
[PubMed - indexed for MEDLINE]
4.

Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.

Volpe DA.

Future Med Chem. 2011 Dec;3(16):2063-77. doi: 10.4155/fmc.11.149. Review.

PMID:
22098353
[PubMed - indexed for MEDLINE]
5.

Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers.

Hubatsch I, Ragnarsson EG, Artursson P.

Nat Protoc. 2007;2(9):2111-9.

PMID:
17853866
[PubMed - indexed for MEDLINE]
6.

Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.

Grès MC, Julian B, Bourrié M, Meunier V, Roques C, Berger M, Boulenc X, Berger Y, Fabre G.

Pharm Res. 1998 May;15(5):726-33.

PMID:
9619781
[PubMed - indexed for MEDLINE]
7.

Permeability for intestinal absorption: Caco-2 assay and related issues.

Press B, Di Grandi D.

Curr Drug Metab. 2008 Nov;9(9):893-900. Review.

PMID:
18991586
[PubMed - indexed for MEDLINE]
8.

Caco-2 cells as a model for intestinal absorption.

Angelis ID, Turco L.

Curr Protoc Toxicol. 2011 Feb;Chapter 20:Unit20.6. doi: 10.1002/0471140856.tx2006s47.

PMID:
21400683
[PubMed - indexed for MEDLINE]
9.

Optimization of the Caco-2 permeability assay to screen drug compounds for intestinal absorption and efflux.

Press B.

Methods Mol Biol. 2011;763:139-54. doi: 10.1007/978-1-61779-191-8_9.

PMID:
21874449
[PubMed - indexed for MEDLINE]
10.

Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics.

Biganzoli E, Cavenaghi LA, Rossi R, Brunati MC, Nolli ML.

Farmaco. 1999 Sep 30;54(9):594-9.

PMID:
10555261
[PubMed - indexed for MEDLINE]
11.

Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.

Ingels F, Beck B, Oth M, Augustijns P.

Int J Pharm. 2004 Apr 15;274(1-2):221-32.

PMID:
15072798
[PubMed - indexed for MEDLINE]
12.

Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa.

Miret S, Abrahamse L, de Groene EM.

J Biomol Screen. 2004 Oct;9(7):598-606.

PMID:
15475479
[PubMed - indexed for MEDLINE]
13.

Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties.

Yang Z, Zadjura LM, Marino AM, D'Arienzo CJ, Malinowski J, Gesenberg C, Lin PF, Colonno RJ, Wang T, Kadow JF, Meanwell NA, Hansel SB.

J Pharm Sci. 2010 Apr;99(4):2135-52. doi: 10.1002/jps.21948.

PMID:
19780144
[PubMed - indexed for MEDLINE]
14.

Permeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system.

Gupta V, Doshi N, Mitragotri S.

PLoS One. 2013;8(2):e57136. doi: 10.1371/journal.pone.0057136. Epub 2013 Feb 27.

PMID:
23483881
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Development of researches in Caco-2 cell model].

Wang C, Qiu Z.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005 Jun;22(3):633-6, 644. Chinese.

PMID:
16013277
[PubMed - in process]
16.

A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model.

Delie F, Rubas W.

Crit Rev Ther Drug Carrier Syst. 1997;14(3):221-86. Review.

PMID:
9282267
[PubMed - indexed for MEDLINE]
17.

Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells.

Kamath AV, Morrison RA, Mathias NR, Dando SA, Marino AM, Chong S.

Arch Pharm Res. 2007 Aug;30(8):1002-7.

PMID:
17879754
[PubMed - indexed for MEDLINE]
18.

Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism.

Li Y, Shin YG, Yu C, Kosmeder JW, Hirschelman WH, Pezzuto JM, van Breemen RB.

Comb Chem High Throughput Screen. 2003 Dec;6(8):757-67. Review.

PMID:
14683481
[PubMed - indexed for MEDLINE]
19.

New and better protocols for a short-term Caco-2 cell culture system.

Yamashita S, Konishi K, Yamazaki Y, Taki Y, Sakane T, Sezaki H, Furuyama Y.

J Pharm Sci. 2002 Mar;91(3):669-79.

PMID:
11920752
[PubMed - indexed for MEDLINE]
20.

Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.

Collett A, Sims E, Walker D, He YL, Ayrton J, Rowland M, Warhurst G.

Pharm Res. 1996 Feb;13(2):216-21.

PMID:
8932439
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk